Health sciences company PreveCeutical Medical (CSE: PREV)
(OTCQB: PRVCF) (FSE: 18H) holds a wide array of advanced therapeutic products
in its development pipeline, including its Sol-gel delivery platform. The
Sol-gel nose-to-brain drug delivery platform delivers a therapeutic compound to
a targeted site at a deliberate, controlled rate. A recent article further
discussing the company reads: “The Sol-gel platform allows a therapeutic agent
to be administered via the nostrils, where it changes rapidly to a gel upon
contact with mucosal tissue. The gel, which continues to line the nasal passage
for up to seven days, slowly releases the therapeutic agent over time. It was
developed in conjunction with the University of Queensland in Australia.
PreveCeutical’s team in Australia recently began testing alternative spray
devices for use with the Sol-gel system, and a non-disclosure agreement has
been signed with one company which has a successful drug approval track record
and good manufacturing standards for pharmaceutical devices.”
To view the full article, visit http://ibn.fm/AvMMi
About PreveCeutical Medical Inc.
PreveCeutical is a health sciences company that develops
innovative options for preventive and curative therapies utilizing organic and
nature identical products. PreveCeutical aims to be a leader in preventive
health sciences and currently has five research and development programs,
including: dual gene therapy for curative and prevention therapies for diabetes
and obesity; the Program; Nature Identical™ peptides for treatment of various
ailments; non-addictive analgesic peptides as a replacement to the highly
addictive analgesics such as morphine, fentanyl and oxycodone; and a
therapeutic product for treating athletes who suffer from concussions (mild
traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster.
CELLB9® is an oral solution containing polarized and potentiated essential
minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion
venom. This product is available on the company’s website. For more
information, visit the company’s website at www.PreveCeutical.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment